|
|
.
See Category: Diseases of the genitourinary system
ICD-10 (CM) Code and Descriptor
|
N01.9 |
Rapidly progressive nephritic syndrome with unspecified morphologic changes
|
N019 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 28.51%
|
21.69%
|
17.30%
|
8.69%
|
8.29%
|
4.31%
|
2.92%
|
1.95%
|
1.54%
|
1.46%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N01.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
203
|
204
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
141
|
141
|
|
80053
|
COMPREHEN METABOLIC PANEL |
95
|
95
|
|
82570
|
ASSAY OF URINE CREATININE |
85
|
88
|
|
84156
|
ASSAY OF PROTEIN URINE |
85
|
85
|
|
80069
|
RENAL FUNCTION PANEL |
78
|
78
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
78
|
78
|
|
96413
|
CHEMO IV INFUSION 1 HR |
77
|
77
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
64
|
129
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
63
|
77
|
|
85027
|
COMPLETE CBC AUTOMATED |
59
|
59
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
59
|
59
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
56
|
2,460
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
48
|
152
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
39
|
88
|
|
83516
|
IMMUNOASSAY NONANTIBODY |
37
|
44
|
|
J1200
|
DIPHENHYDRAMINE HCL INJECTIO |
35
|
36
|
|
83735
|
ASSAY OF MAGNESIUM |
34
|
34
|
|
80048
|
METABOLIC PANEL TOTAL CA |
34
|
34
|
|
83970
|
ASSAY OF PARATHORMONE |
31
|
32
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N01.9 related to the following DRG Codes:
698-700
791
793
|
